NOTRELOAD AI
  • NOTRELOAD AI
  • myNOTRELOAD
  • One-Time License
  • Invest ↗
  • XY Feed
  • Push Notifications
Sign in Subscribe

FuboTV Stock Plunges Despite ESPN Partnership and Revenue Growth

FuboTV (FUBO) shares drop 21% to $1.79 after reporting Q1 losses, despite 40% revenue jump and new ESPN distribution deal. Company plans reverse stock split.

FuboTV Stock Plunges Despite ESPN Partnership and Revenue Growth
Credit: FuboTV
Already have an account? Sign in.
02/03/2026 · 11:05 AM
FUBO
/ Don’t stop at just one post.

Related↓

FuboTV Stock Surges as Company Forecasts Positive Free Cash Flow by 2027
04/06/2026 · 1:05 PM

FuboTV Stock Surges as Company Forecasts Positive Free Cash Flow by 2027

FuboTV stock jumped on strong outlook. It may turn cash-positive by 2027 and grow fast, with enough cash to fund operations through 2028.

/ Subscriber only
/ Read more

Feed↓

Wall Street Initiates Coverage of Lycia Therapeutics with Buy Ratings on Extracellular Degrader Platform
11/17/2026 · 12:43 PM

Wall Street Initiates Coverage of Lycia Therapeutics with Buy Ratings on Extracellular Degrader Platform

Multiple analysts initiated Buy ratings on Lycia Therapeutics, pointing to its differentiated LYTAC platform and potential in the growing food allergy market.

/ Subscriber only
TPG Close to Taking Payments Platform Bill Holdings Private
11/17/2026 · 12:07 PM

TPG Close to Taking Payments Platform Bill Holdings Private

The payments software firm has faced activist pressure.

/ Subscriber only
Jensen Huang Says He Is Open to Returning as Nvidia CEO
Featured/ 11/17/2026 · 11:41 AM

Jensen Huang Says He Is Open to Returning as Nvidia CEO

In his first statement since resigning, former Nvidia CEO Jensen Huang expressed regret and said he would return if the board wants him.

/ Subscriber only
Explore
  • NOTRELOAD AI
  • myNOTRELOAD
  • One-Time License
  • Invest ↗
  • XY Feed
  • Push Notifications
More
  • Sign up
  • Sign in
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Terms/Privacy
  • UP↑
Get alerts

Be the first to know when deals break, stocks move, or biotech headlines hit.

Email address Subscribe
DON'T FALL BEHIND. ©2026
For informational purposes only. Not financial advice.
NOTRELOAD AI